• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接启动子诱导 p19Arf 表达,解释了依赖受体 RET/Pit-1/p53 诱导的垂体生长激素细胞凋亡。

Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.

机构信息

IDIS-Neoplasia and Endocrine Differentiation, Department of Physiology, CIMUS, School of Medicine, University of Santiago de Compostela USC, Santiago de Compostela, Spain.

出版信息

Oncogene. 2012 Jun 7;31(23):2824-35. doi: 10.1038/onc.2011.458. Epub 2011 Oct 24.

DOI:10.1038/onc.2011.458
PMID:22020338
Abstract

Somatotrophs produce growth hormone (GH) and are the most abundant secretory cells of the pituitary. Somatotrophs express the transcription factor Pit-1 and the dependence receptor RET, its co-receptor GFRa1 and ligand GDNF. Pit-1 is a transcription factor essential for somatotroph proliferation and differentiation and for GH expression. GDNF represses excess Pit-1 expression preventing excess GH. In the absence of GDNF, RET behaves as a dependence receptor, becomes intracellularly processed and induces strong Pit-1 expression leading to p53 accumulation and apoptosis. How accumulation of Pit-1 leads to p53 expression is unknown. We have unveiled the relationship of Pit-1 with the p19Arf gene. There is a parallel correlation of RET processing, Pit-1 increase and ARF protein and mRNA expression. Interfering the pathway with RET, Pit-1 or p19Arf siRNA blocked apoptosis. We have found a Pit-1 DNA-binding element within the ARF promoter. Pit-1 directly regulates the CDKN2A locus and binds to the p19Arft promoter inducing p19Arf gene expression. The Pit-1-binding element is conserved in rodents and humans. RET/Pit-1 induces p19Arf/p53 and apoptosis not only in a somatotroph cell line but also in primary cultures of pituitary somatotrophs, where ARF siRNA interference also blocks p53 and apoptosis. Analyses of the somatotrophs in whole pituitaries supported the above findings. Thus Pit-1, a differentiation factor, activates the oncogene-induced apoptosis (OIA) pathway as oncogenes exerting a tight control in somatotrophs to prevent the disease due to excess of GH (insulin-resistance, metabolic disease, acromegaly).

摘要

生长激素细胞(GH)是脑垂体中分泌生长激素(GH)的最主要细胞,它们表达转录因子 Pit-1 和依赖性受体 RET、其共同受体 GFRa1 和配体 GDNF。Pit-1 是生长激素细胞增殖和分化以及 GH 表达所必需的转录因子。GDNF 抑制 Pit-1 过度表达,防止 GH 过量。在缺乏 GDNF 的情况下,RET 作为依赖性受体,被细胞内加工,并诱导强烈的 Pit-1 表达,导致 p53 积累和细胞凋亡。Pit-1 如何导致 p53 表达尚不清楚。我们揭示了 Pit-1 与 p19Arf 基因的关系。RET 加工、Pit-1 增加和 ARF 蛋白和 mRNA 表达之间存在平行相关性。用 RET、Pit-1 或 p19Arf siRNA 干扰该途径可阻断细胞凋亡。我们在 ARF 启动子内发现了一个 Pit-1 DNA 结合元件。Pit-1 直接调节 CDKN2A 基因座,并结合 p19Arf 启动子,诱导 p19Arf 基因表达。Pit-1 结合元件在啮齿动物和人类中是保守的。RET/Pit-1 不仅在生长激素细胞系中,而且在垂体生长激素细胞的原代培养物中诱导 p19Arf/p53 和细胞凋亡,而 ARF siRNA 干扰也可阻断 p53 和细胞凋亡。对整个垂体中的生长激素细胞进行的分析支持了上述发现。因此,作为一种分化因子的 Pit-1,激活了癌基因诱导的凋亡(OIA)途径,因为癌基因在生长激素细胞中发挥严格的控制作用,以防止因 GH 过量而导致的疾病(胰岛素抵抗、代谢疾病、肢端肥大症)。

相似文献

1
Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.直接启动子诱导 p19Arf 表达,解释了依赖受体 RET/Pit-1/p53 诱导的垂体生长激素细胞凋亡。
Oncogene. 2012 Jun 7;31(23):2824-35. doi: 10.1038/onc.2011.458. Epub 2011 Oct 24.
2
The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.依赖受体Ret通过Pit-1/p53途径诱导生长激素细胞凋亡,从而抑制肿瘤生长。
EMBO J. 2007 Apr 18;26(8):2015-28. doi: 10.1038/sj.emboj.7601636. Epub 2007 Mar 22.
3
Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.生长激素细胞瘤,但不是无功能垂体腺瘤,维持着一种功能性凋亡 RET/Pit1/ARF/p53 途径,该途径可被过量 GDNF 阻断。
Endocrinology. 2014 Nov;155(11):4329-40. doi: 10.1210/en.2014-1034. Epub 2014 Aug 19.
4
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.从肢端肥大症的 GDNF-RET/PIT1/p14ARF/p53 通路中揭示新的预后标志物和治疗靶点。
EBioMedicine. 2019 May;43:537-552. doi: 10.1016/j.ebiom.2019.04.007. Epub 2019 Apr 8.
5
Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary.RETR 依赖性受体、GFRa 共受体及其配体在垂体中的功能作用。
Front Horm Res. 2010;38:127-138. doi: 10.1159/000318502. Epub 2010 Jul 5.
6
Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.在非人类灵长类动物模型埃及狒狒中研究代谢因素对生长激素细胞功能的直接影响。
J Mol Endocrinol. 2006 Aug;37(1):25-38. doi: 10.1677/jme.1.02042.
7
The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.细胞周期蛋白依赖性激酶4a/可变阅读框(INK4a/ARF)基因座编码的蛋白p16INK4a和p19ARF通过不同的顺式元件抑制细胞周期蛋白D1的转录。
Cancer Res. 2004 Jun 15;64(12):4122-30. doi: 10.1158/0008-5472.CAN-03-2519.
8
GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression.生长激素释放激素对生长激素细胞的增殖作用具有细胞类型特异性,且依赖于Pit-1/GHF-1的表达。
J Cell Physiol. 2008 Apr;215(1):140-50. doi: 10.1002/jcp.21295.
9
[The mechanism of interferon-gamma increases growth hormone expression in rat pituitary GH(3) cells].[干扰素-γ增加大鼠垂体GH(3)细胞中生长激素表达的机制]
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Sep;34(5):619-24.
10
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.RET 信号转导为 AIP 相关生长激素细胞瘤提供了致瘤机制和组织特异性。
Oncogene. 2021 Nov;40(45):6354-6368. doi: 10.1038/s41388-021-02009-8. Epub 2021 Sep 29.

引用本文的文献

1
RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.RET 信号转导为 AIP 相关生长激素细胞瘤提供了致瘤机制和组织特异性。
Oncogene. 2021 Nov;40(45):6354-6368. doi: 10.1038/s41388-021-02009-8. Epub 2021 Sep 29.
2
Sequential Colocalization of ERa, PR, and AR Hormone Receptors Using Confocal Microscopy Enables New Insights into Normal Breast and Prostate Tissue and Cancers.使用共聚焦显微镜对雌激素受体(ERα)、孕激素受体(PR)和雄激素受体(AR)激素受体进行序列共定位,能够为正常乳腺和前列腺组织及癌症提供新的见解。
Cancers (Basel). 2020 Nov 30;12(12):3591. doi: 10.3390/cancers12123591.
3
GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells.
RET的GFRα 1-2-3-4共受体在垂体干细胞中共同表达,但在一些腺垂体细胞中单独保留。
Front Endocrinol (Lausanne). 2020 Sep 24;11:631. doi: 10.3389/fendo.2020.00631. eCollection 2020.
4
The p14ARF tumor suppressor restrains androgen receptor activity and prevents apoptosis in prostate cancer cells.抑癌基因 p14ARF 抑制雄激素受体活性并防止前列腺癌细胞凋亡。
Cancer Lett. 2020 Jul 28;483:12-21. doi: 10.1016/j.canlet.2020.03.030. Epub 2020 Apr 21.
5
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.从肢端肥大症的 GDNF-RET/PIT1/p14ARF/p53 通路中揭示新的预后标志物和治疗靶点。
EBioMedicine. 2019 May;43:537-552. doi: 10.1016/j.ebiom.2019.04.007. Epub 2019 Apr 8.
6
The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.中枢性甲状腺功能减退症和巨大睾丸症综合征:IGSF1 通过调节垂体 TGFβ 和激活素途径来控制 TRHR 和 FSHB 的表达。
Sci Rep. 2017 Mar 6;7:42937. doi: 10.1038/srep42937.
7
Regulation of pituitary stem cells by epithelial to mesenchymal transition events and signaling pathways.上皮-间质转化事件和信号通路对垂体干细胞的调控
Mol Cell Endocrinol. 2017 Apr 15;445:14-26. doi: 10.1016/j.mce.2016.09.016. Epub 2016 Sep 17.
8
Dose-dependent dual role of PIT-1 (POU1F1) in somatolactotroph cell proliferation and apoptosis.PIT-1(POU1F1)在生长催乳素细胞增殖和凋亡中的剂量依赖性双重作用。
PLoS One. 2015 Mar 30;10(3):e0120010. doi: 10.1371/journal.pone.0120010. eCollection 2015.
9
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.新兴的垂体腺瘤靶点:CXCL12/CXCR4-R7 系统的作用。
Int J Endocrinol. 2014;2014:753524. doi: 10.1155/2014/753524. Epub 2014 Nov 17.
10
RET revisited: expanding the oncogenic portfolio.RET 再探:扩展致癌基因谱。
Nat Rev Cancer. 2014 Mar;14(3):173-86. doi: 10.1038/nrc3680.